StoneX Group Inc. heads into its May 6 fiscal Q2 results with a 32% monthly price surge behind it and a conspicuous wave of insider selling in its wake.
The insider activity is the most striking feature of the current setup. The CEO, Philip Smith, sold 30,000 shares on April 10 at $92.23, raising $2.8 million. Executive Vice Chairman Sean O'Connor sold 44,269 shares on March 31 at $77.95 — followed by two tranches of 40,000 shares each in February at prices above $124, collecting nearly $10 million across those two days alone. The President and Chief Risk Officer each sold 30,000 and 40,000 shares respectively on the same February date. Net insider activity over the past 90 days totals a disposal of roughly $26.3 million in value. These are senior figures trimming at multiple points across a broad price range, not routine post-vest housekeeping.
Options traders are reading the setup differently — they lean bullish. The put/call ratio dropped to 0.44, well below its 20-day average of 0.53, placing current positioning on the call-heavy side of recent history. That compares against a 52-week high PCR of 2.05, so the current reading is far from defensive. The short score of 44.1 is mid-range and has barely moved this week, reinforcing the sense that bears are not pressing hard. Short interest — at approximately 4.7% of the free float on an ORTEX estimate basis — has edged up around 1.6% over the week and 12.5% over the month, though the absolute level remains modest. Borrow costs of 0.47% are negligible and have been flat for weeks. Availability has not tightened meaningfully, with the borrow market running well short of stressed levels, which leaves no mechanical pressure on any existing short positions.
The Street is cautiously constructive but not stretched. The mean analyst price target is $107, barely 3% above the close of $103.65 — a gap that suggests the stock has run through a significant chunk of the consensus target range during its April rally. The RSI14 is at 76, in overbought territory, and the stock is up 65.5% year-to-date. Jefferies raised its target to $122 in early February — the most recent specific move on record — maintaining a Buy. William Blair began coverage as recently as March 2025 with an Outperform rating. Despite the positive ratings, analyst return potential has been compressed to under 2% by the price move, and the analyst recommendation differential sits at only the 49th percentile. The institutional register shows BlackRock adding 490,000 shares and Vanguard adding nearly 791,000 shares as of March 31, providing some counterweight to the insider flow. Days-to-cover at 9 is relatively elevated for a stock with this borrow profile — the FINRA fortnightly settlement figure as of April 15 put official short interest at 3.25 million shares with DTC of 3.77 days, a divergence that bears watching as the estimates-based figure climbs.
The earnings reaction history adds one further layer to consider. The last confirmed print, in early February, produced a one-day move of 2.7% and a five-day move of 6.5%. A prior event showed a sharper single-day reaction of 10% and a five-day follow-through of 12.2%. The stock has not punished shareholders in recent quarters, but the combination of an elevated RSI, insider disposals across the senior leadership bench, and a price target that offers only marginal upside means May 6 is less a straightforward catalyst and more a test of whether fundamental momentum justifies the multiple expansion seen this spring.
The question heading into next week is whether Q2 results can extend the narrative that has driven a 65% YTD gain, or whether the insider activity signals that those closest to the business see the current valuation as full.
See the live data behind this article on ORTEX.
Open SNEX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
